# Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.

> **NCT01276054** · PHASE2 · TERMINATED · sponsor: **University of Southern California** · enrollment: 4 (actual)

## Conditions studied

- Lymphedema
- Recurrent Breast Cancer
- Stage IA Breast Cancer
- Stage IB Breast Cancer
- Stage II Breast Cancer

## Interventions

- **RADIATION:** technetium Tc 99m sulfur colloid
- **DRUG:** methylene blue
- **DRUG:** indocyanine green solution
- **PROCEDURE:** sentinel lymph node biopsy
- **PROCEDURE:** axillary lymph node biopsy
- **PROCEDURE:** bioimpedance spectroscopy
- **PROCEDURE:** quality-of-life assessment
- **OTHER:** lymphedema management

## Key facts

- **NCT ID:** NCT01276054
- **Lead sponsor:** University of Southern California
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2010-12
- **Primary completion:** 2011-10
- **Final completion:** 2011-10
- **Target enrollment:** 4 (ACTUAL)
- **Why stopped:** P.I. left
- **Last updated:** 2014-08-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01276054

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01276054, "Sentinel and/or Axillary Lymph Node Biopsy With or Without Axillary Reverse Mapping in Reducing Incidence and Severity of Arm Lymphedema in Stage 0-2 Patients.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT01276054. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*